Beacon CVRM Database Early Access
Beacon CVRM is coming soon! To celebrate we are offering founding partners, exclusive early access to Beacon CVRMs Obesity drug development data.
Gain early access to 750+ drugs and 1,300+ trials in the Obesity space.
Become a Beacon CVRM founding partner and secure early access today!
Beacon CVRM Database Summary
- Unrivaled comprehensive & accurate preclinical and clinical Cardiovascular, Renal, and Metabolic drug and trial data.
- Access to 7,000+ Drugs and 20,000+ Trials, in the CVRM space.
- Market leading ontologies, enabling precise navigation of the CVRM drug discovery & development landscape
- Manually curated by CVRM scientists, with data updated daily
- Your one stop shop for CVRM drug development intelligence data.
Why Beacon CVRM Database?
How Beacon CVRM Database Can Help You?
With the CVRM pipeline expanding at record speed and next generation therapeutics driving unprecedented innovation, staying ahead of the latest breakthroughs is essential to maintain a competitive edge in an increasingly dynamic and fast-moving market.
It is more crucial than ever to use gold-standard data for every go/no-go decision and adapt to market changes in real time to mitigate risk and provide the best chance of success.
Benchmark your preclinical CVRM research with confidence, by accessing preclinical CVRM drug discovery and development results data from scientific publications, conference abstracts, posters, investor decks and more. Links to the source material (including conference posters) are included.
Access standardized and manually curated preclinical data including, in vitro and in vivo results, efficacy, toxicity and PK reads-outs.
Secure a strategic advantage by accessing real-time data into 20,000+ CVRM clinical trials (from early to late stage). Monitor the competitive landscape with unmatched granularity, with insight into patient selection criteria, trial end point design, drug dosing strategy, toxicity, clinical trial results, and more
Beacon enables users to systematically track developer CVRM disorder pipelines through advanced search and filtering tools. The platform provides continuously updated data on drug development status, mechanism of action, and clinical trial stage, offering clear visibility into the evolving competitive CVRM drug development landscape.
Beacon CVRM Database: The Numbers
Beacon CVRM Database: Key Data Segments
Drug Data
Revolutionize your searching of the CVRM drug development landscape.
Utilize >20 search filters to find programs based on disease indication, drug modality, drug target and many more.
Trial Data
Optimize your CVRM clinical trial design searching capabilities.
Seamlessly benchmark clinical trial results and search the CVRM trial landscape based on drug technologies, combination trials, trial phase, disease indication and more.
Beacon CVRM Database Scope
Analyze 7,000+ drugs (preclinical and clinical) and 20,000+ clinical trials (from early to later stage)
Beacon CVRM covers pharmaceutical interventions for Cardiovascular, Renal and Metabolic-related diseases including:
- Cardiovascular Diseases: Hypertension, Heart Attack, Coronary Artery Disease, Cardiomyopathies, Heart Failure, and Stroke
- Diabetes: Type 2 Diabetes, Prediabetes, and Diabetic complications, (such as Diabetic Retinopathy, Neuropathy, and Nephropathy)
- Metabolic Liver Disease: MASLD, MASH, Hepatic Fibrosis, and Hepatic Cirrhosis
- Obesity: Adult, Childhood, and Rare Genetic Obesity
- Renal Diseases: Chronic, Diabetic, Hypertension-related & Metabolic Kidney Disease, and Cardiorenal Syndrome
- Obstructive Sleep Apnoea
- Osteoarthritis
Beacon CVRM also includes a host of preclinical data including, cell line and animal model experimental data.
Key Disease Exclusions:
All CVRM-related diseases with a genetic origin
Who is Beacon CVRM Database For?
Beacon CVRM is a manually curated database of comprehensive, high quality, and accurate, preclinical and clinical drug and trial data, offering unrivalled insight into the Psychiatric drug development landscape.
Commercial deal and company data will be added to the dataset soon!
Scientific Strategy Leader
Select the right pipeline for your CVRM drug development
Research Scientist
Validate new targets & inform your CVRM drug design
Clinical Development
Design optimized CVRM clinical trials & benchmark against the competition
Business Development
Uncover new CVRM drug licensing, partnership and fundraising opportunities
Competitive Intelligence
Track competitive threats & emerging CVRM technologies
Translational Development
Confidently take your preclinical CVRM drug into the clinic
Related Resources
Check out Neuroscience related resources available from Beacon
Our Experts
Charlotte Abraham
Lead Research Analyst,
Beacon CVRM
Jake Morris